Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Neopharm licenses pulmonary fibrosis drug
Financial terms of the agreement were not disclosed. Idiopathic pulmonary fibrosis (IPF), a type of pulmonary fibrosis, is a progressive disorder affecting approximately 200,000 Americans and over five
Financial terms of the agreement were not disclosed. Idiopathic pulmonary fibrosis (IPF), a type of pulmonary fibrosis, is a progressive disorder affecting approximately 200,000 Americans and over five
The double-blind, placebo-controlled trial will take place at seven sites in the US, enrolling up to 150 female MS patients who have been recently diagnosed with relapsing-remitting MS.
The vaccine is designed to prevent diphtheria, pertussis or whooping cough, polio, tetanus and Haemophilus influenzae type b. It is sold in nine countries including Canada. A spokesperson
Irinotecan is a generic chemotherapy agent, marketed in the US as Camptosar. In preclinical studies, Davanat has demonstrated it significantly improves irinotecan activity in the tumor as measured
The companies want the label to include additional information that Erbitux improves overall survival in the third-line treatment of patients with metastatic colorectal cancer The FDA has granted
The alliance combines Archemix’s proprietary Selex technology to discover and generate aptamer candidates with Merck’s demonstrated oncology drug development and commercialization capabilities, according to the companies. In addition
The goal of the trial was to develop a four-month formulation of triptorelin, the active ingredient in Decapeptyl, a treatment for hormone sensitive prostate cancer. Ipsen’s goal remains
Archemix plans to present a complete data set from this phase I clinical trial within a peer-reviewed forum in 2007. The drug, ARC1779, is designed to selectively block
The results were from the second of the two successful phase III placebo-controlled clinical trials evaluating the efficacy and safety of Frova in menstrual migraine (MM) prophylaxis. Women
The drug achieved the results without evidence of post operative residual curarization (PORC) or re-occurrence of muscle relaxation, Organon added. The trial compared the efficacy of sugammadex and